Found: 8
Select item for more details and to access through your institution.
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00355-2
- By:
- Publication type:
- Article
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00181-4
- By:
- Publication type:
- Article
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of KRAS<sup>G12C</sup> inhibitor responses in novel murine KRAS<sup>G12C</sup> lung cancer cell line models.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1094123
- By:
- Publication type:
- Article
Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082236
- By:
- Publication type:
- Article
Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0014117
- By:
- Publication type:
- Article
Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data.
- Published in:
- Bioinformatics, 2015, v. 31, n. 23, p. 3799, doi. 10.1093/bioinformatics/btv427
- By:
- Publication type:
- Article